Abstract
Four new hybrid analogues of 1α,25-dihydroxyvitamim D3 (1) have been synthesized in a convergent manner by joining A-ring and C,D-ring fragments. Each hybrid analogue, having a noncalcemic 1-hydroxymethyl group and a potentiating 16-ene 24,24-difluorinated C,D-ring side chain, was designed to be lipophilic and inert toward 24-hydroxylase enzyme catabolism. Each hybrid analogue with lβ,3α-substituent stereochemistry (i.e., analogues 3b and 4b) showed a pharmacologically desirable combination of in vitro high antiproliferative activity in two different cell lines and high transcriptional activity with also low calcemic activity in vivo.
Original language | English (US) |
---|---|
Pages (from-to) | 3008-3014 |
Number of pages | 7 |
Journal | Journal of medicinal chemistry |
Volume | 41 |
Issue number | 16 |
DOIs | |
State | Published - Jul 30 1998 |
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery